Clinical Trial Update: Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating injectable Neucardin for improving cardiac function in chronic systolic heart failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systolic Heart Failure

Drugs mentioned

• Neucardin (neucardin)

Snippet

Sponsor: Zensun Sci. & Tech. Co., Ltd. | Conditions: Chronic Systolic Heart Failure | Phase 3 | Status: COMPLETED